130 related articles for article (PubMed ID: 6839760)
41. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
Holman CD; Armstrong BK; Heenan PJ
Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
[TBL] [Abstract][Full Text] [Related]
42. Prolactin-secreting pituitary adenomas in women. II. Menstrual function, pituitary reserves, and prolactin production following microsurgical removal.
Keye WR; Chang RJ; Monroe SE; Wilson CB; Jaffe RB
Am J Obstet Gynecol; 1979 Jun; 134(4):360-5. PubMed ID: 222148
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
Scott JZ; Kletzky OA; Brenner PF; Mishell DR
Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
[TBL] [Abstract][Full Text] [Related]
44. Elevated prolactin levels in oral contraceptive pill-related hypertension.
Lehtovirta P; Ranta T; Seppälä M
Fertil Steril; 1981 Apr; 35(4):403-5. PubMed ID: 6783445
[TBL] [Abstract][Full Text] [Related]
45. Ultrasound evaluation of ovarian activity under oral contraceptives.
Hoogland HJ; Skouby SO
Contraception; 1993 Jun; 47(6):583-90. PubMed ID: 8334892
[TBL] [Abstract][Full Text] [Related]
46. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
Snowden EU; Khan-Dawood FS; Dawood MY
Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893
[TBL] [Abstract][Full Text] [Related]
47. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
[TBL] [Abstract][Full Text] [Related]
48. [Oral steroid contraception in hyperprolactinemia (author's transl)].
Völker W; Reitmann I; Kannengiesser U; Niesert S; Gehring WG; von zur Mühlen A
Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):199-203. PubMed ID: 7215761
[TBL] [Abstract][Full Text] [Related]
49. Pituitary adenomas and oral contraceptives: a multicenter case-control study.
Fertil Steril; 1983 Jun; 39(6):753-60. PubMed ID: 6682810
[TBL] [Abstract][Full Text] [Related]
50. Iron status in Danish women aged 35-65 years. Relation to menstruation and method of contraception.
Milman N; Rosdahl N; Lyhne N; Jørgensen T; Graudal N
Acta Obstet Gynecol Scand; 1993 Nov; 72(8):601-5. PubMed ID: 8259744
[TBL] [Abstract][Full Text] [Related]
51. Prolonged over-suppression syndrome.
Good AE; Kempers RD
Med Clin North Am; 1974 Jul; 58(4):861-7. PubMed ID: 4858289
[TBL] [Abstract][Full Text] [Related]
52. Fertility after contraception or abortion.
Huggins GR; Cullins VE
Fertil Steril; 1990 Oct; 54(4):559-73. PubMed ID: 2209874
[TBL] [Abstract][Full Text] [Related]
53. Oral contraceptives and skin neoplasia.
Green A
Contraception; 1991 Jun; 43(6):653-66. PubMed ID: 1868736
[TBL] [Abstract][Full Text] [Related]
54. Hyperprolactinemia in cases of infertility and amenorrhea.
Furuhjelm M; Rydner T; Carlström K
Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
[TBL] [Abstract][Full Text] [Related]
55. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
[TBL] [Abstract][Full Text] [Related]
56. Spontaneous regression of prolactin-producing pituitary adenomas.
Vaughn TC; Haney AF; Wiebe RH; Kramer RS; Hammond CB
Am J Obstet Gynecol; 1980 Apr; 136(8):980-2. PubMed ID: 7189326
[TBL] [Abstract][Full Text] [Related]
57. [Oral contraception: failures and risks].
Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
[TBL] [Abstract][Full Text] [Related]
58. Clinical experience with a triphasic oral contraceptive.
Ulstein M; Svendsen E; Steier A; Bratt H; Fylling P; Lie S; Schiefloe A; Aaserud J
Acta Obstet Gynecol Scand; 1984; 63(3):233-6. PubMed ID: 6428157
[TBL] [Abstract][Full Text] [Related]
59. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.
Gordon SC; Reddy KR; Livingstone AS; Jeffers LJ; Schiff ER
Ann Intern Med; 1986 Oct; 105(4):547-9. PubMed ID: 3019201
[TBL] [Abstract][Full Text] [Related]
60. Some aspects of studies with oral contraceptives in Indian women.
Shah PN
J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
